Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-26 @ 1:52 PM
Study NCT ID:
NCT03961659
Status:
UNKNOWN
Last Update Posted:
2019-05-23
First Post:
2019-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.
Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-02
Completion Date Type:
ESTIMATED
First Submit Date:
2019-05-19
First Submit QC Date:
None
Study First Post Date:
2019-05-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-22
Last Update Post Date:
2019-05-23
Last Update Post Date Type:
ACTUAL